PP
ENZN

Paloma Partners’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Paloma Partners’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-161,481
Closed -$168K – 1498
2014
Q2 		$168K Buy
+161,481
New +$154K 0.01% 994
2013
Q4 		– Sell
-25,800
Closed -$43K – 1298
2013
Q3 		$43K Buy
+25,800
New +$47.7K ﹤0.01% 886

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Paloma Partners's ENZN Position: Q3 2014 in Review

Paloma Partners sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2014, closing a stake of 161,481 shares — an estimated $168K sold.

Paloma Partners first reported a position in ENZN in Q3 2013 and held it in 2 quarters. The position peaked at $168K in Q2 2014. 65 funds tracked by Wall St. Rank hold ENZN as of Q3 2014.

  • Paloma Partners reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Paloma Partners sold 161,481 ENZON PHARMACEUTICALS INC shares in Q3 2014, an estimated $168K.
  • Paloma Partners first reported a position in ENZON PHARMACEUTICALS INC in Q3 2013 and held it in 2 quarters.
  • Paloma Partners's ENZON PHARMACEUTICALS INC position peaked at $168K in Q2 2014.
  • 65 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2014.

Based on Paloma Partners's 13F filing for Q3 2014, filed 14 Nov 2014.